ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Pulmonx Corporation

Pulmonx Corporation (LUNG)

5.71
0.02
( 0.35% )
Updated: 14:04:36

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
5.71
Bid
5.70
Ask
5.72
Volume
138,606
5.63 Day's Range 5.86
5.46 52 Week Range 14.92
Market Cap
Previous Close
5.69
Open
5.69
Last Trade
1
@
5.7115
Last Trade Time
14:08:39
Financial Volume
US$ 795,091
VWAP
5.7363
Average Volume (3m)
213,256
Shares Outstanding
39,487,879
Dividend Yield
-
PE Ratio
-3.71
Earnings Per Share (EPS)
-1.54
Revenue
68.68M
Net Profit
-60.84M

About Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment ... Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Pulmonx Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LUNG. The last closing price for Pulmonx was US$5.69. Over the last year, Pulmonx shares have traded in a share price range of US$ 5.46 to US$ 14.92.

Pulmonx currently has 39,487,879 shares outstanding. The market capitalization of Pulmonx is US$224.69 million. Pulmonx has a price to earnings ratio (PE ratio) of -3.71.

LUNG Latest News

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.35-5.775577557766.066.3555.631410956.05120004CS
4-0.89-13.48484848486.67.275.632150176.47194325CS
12-1.74-23.3557046987.457.6655.632132566.44304898CS
26-1.39-19.57746478877.18.795.462487096.79143716CS
52-7.5-56.775170325513.2114.925.463702388.23039951CS
156-17.24-75.119825708122.9529.254.0738983412.11973787CS
260-32.29-84.97368421053869.47794.0737376320.59040016CS

LUNG - Frequently Asked Questions (FAQ)

What is the current Pulmonx share price?
The current share price of Pulmonx is US$ 5.71
How many Pulmonx shares are in issue?
Pulmonx has 39,487,879 shares in issue
What is the market cap of Pulmonx?
The market capitalisation of Pulmonx is USD 224.69M
What is the 1 year trading range for Pulmonx share price?
Pulmonx has traded in the range of US$ 5.46 to US$ 14.92 during the past year
What is the PE ratio of Pulmonx?
The price to earnings ratio of Pulmonx is -3.71
What is the cash to sales ratio of Pulmonx?
The cash to sales ratio of Pulmonx is 3.28
What is the reporting currency for Pulmonx?
Pulmonx reports financial results in USD
What is the latest annual turnover for Pulmonx?
The latest annual turnover of Pulmonx is USD 68.68M
What is the latest annual profit for Pulmonx?
The latest annual profit of Pulmonx is USD -60.84M
What is the registered address of Pulmonx?
The registered address for Pulmonx is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Pulmonx website address?
The website address for Pulmonx is www.pulmonx.com
Which industry sector does Pulmonx operate in?
Pulmonx operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCTMTCTM Kids IT Education Inc
US$ 0.7754
(328.16%)
685.38M
REBNReborn Coffee Inc
US$ 3.427
(68.82%)
54.1M
CYCNCyclerion Therapeutics Inc
US$ 3.7658
(48.26%)
75.98M
SOPASociety Pass Inc
US$ 1.41
(43.29%)
10.34M
FCUVFocus Universal Inc
US$ 5.28
(40.88%)
1.11M
ENVBEnveric Biosciences Inc
US$ 2.0301
(-47.95%)
1.43M
NIVFNewGenIvf Group Ltd
US$ 0.1495
(-42.28%)
13.58M
GLSTGlobal Star Acquisition Inc
US$ 8.55
(-41.03%)
16.66k
BHILBenson Hill Inc
US$ 2.4899
(-36.96%)
2.32M
SPGCSacks Parente Golf Inc
US$ 0.6634
(-26.40%)
5.42M
TCTMTCTM Kids IT Education Inc
US$ 0.77549
(328.21%)
684M
RIMEAlgorhythm Holdings Inc
US$ 0.0265
(8.61%)
283.53M
NVDANVIDIA Corporation
US$ 121.23
(-2.74%)
274.84M
CLEUChina Liberal Education Holdings Ltd
US$ 0.202035
(36.33%)
207.69M
NXUNXU Inc
US$ 0.3379
(41.74%)
183.32M

Discussion

View Full Feed
kayak_wench kayak_wench 2 minutes ago
I too have been wondering about the 2 years without a BE. We know this:
- our investment in R&D is healthy each quarter showing Nasrat is investing in future products.
- Nasrat pretty much blew off any questions about R&D last CC and said they have it handled.
- Nasrat is
ELTP
Monksdream Monksdream 3 minutes ago
XPON, new 52/week low
https://investorshub.advfn.com/uimage/uploads/2025/1/31/z[vbwIMG_4954.gif
XPON
delerious1 delerious1 3 minutes ago
Hydrogen alliance signs MOUs with 4 countries
KNOW-HOW: Taiwan has some of the most comprehensive resources for developing hydrogen fuel cells, and plans to work with international partners, an industry advocate said
Staff writer, with CNA




Golden Cross Golden Cross 3 minutes ago
Yep, 23,298 post here on this board alone... No posts on any other board for ~4 years
https://investorshub.advfn.com/boards/profileb.aspx?user=157508
BIEL
vlispxpert vlispxpert 3 minutes ago
wow, market hating 10y/usd spike...80% cash now!
Lime Time Lime Time 3 minutes ago
Went to Expert Market
WCUI
Trooperstocks Trooperstocks 3 minutes ago
$BURU in Recent news! @marketwatch
https://marketwatch.com/investing/stock/buru
@nuburulasers #investors #NYSE @NYSE
BURU
Trooperstocks Trooperstocks 3 minutes ago
$BURU in Recent news! @marketwatch
https://marketwatch.com/investing/stock/buru
@nuburulasers #investors #NYSE @NYSE
BURU
dukeb dukeb 3 minutes ago
I don't think there's much mystery on how we can save the globe. It's getting businesses and government to take action before it's too late.

You and your son might enjoy this NPR Marketplace piece:

https://www.marketplace.org/2025/01/21/carbon-capture-steel-slag/
docj docj 4 minutes ago
NikNak1, please review the rules IH has regarding posting. I believe posts regarding deletions are not about CYDY and therefore considered off topic.
I look forward to reading more of your posts in the future.
CYDY
Flobewan Flobewan 4 minutes ago
LMAO, good one
Jay_B Jay_B 4 minutes ago
They never submitted an attorney letter with the last annual report, nor did they bother to submit a revised annual report to get back to Pink Current. Instead, they just disappeared into thin air. Poof.
SFLM
236T568 236T568 4 minutes ago
Whoaaaa!

https://bsky.app/profile/katzish.bsky.social/post/3lh2ssp5kas24
Trooperstocks Trooperstocks 4 minutes ago
100% All Organic $SGTM -Trust the Water Less Garden® LIFESTYLE for a safe and healthy environment for your loved ones.
https://img1.wsimg.com/isteam/stock/3705/:/cr=t:0%25,l:21.59%25,w:66.67%25,h:100%25/rs=w:1200,h:1200,cg:true
SGTM
gshores gshores 4 minutes ago
Bullish indeed!!!
SPZI
dewophile dewophile 4 minutes ago
I bet this would slip through - enta has no prospects according to the market, there is no market now for rsv antivirals anyway, they could argue they want the flexiblity of combining 938 with their own drug and or 323 to try and get anythign across the finish line
so yeah i think shionogi co
ENTA
clintonj clintonj 5 minutes ago
It's not. Wamu is not mentioned at all. Smh
COOP
flipper44 flipper44 5 minutes ago
Did you speak with the PR department?
NWBO
Trooperstocks Trooperstocks 5 minutes ago
$SGTM Build your own chemical-free outdoor oasis today.
https://img1.wsimg.com/isteam/stock/25464/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:1200,cg:true
SGTM
BigBadWolf BigBadWolf 5 minutes ago
Should all be completely honest today’s PR was not what anyone believed was forthcoming & should have come after either a Conference update, release of the 5 year plan or after both.
The Good The Bad & The Ugly
RDAR
misterfishman misterfishman 5 minutes ago
its in finra,s hands now contact them if they respond at all.
IGPK
ElectricJester54 ElectricJester54 5 minutes ago
Ya the biggest problem we have consistently had is a lack of new investors. Exactly why I said yesterday that at a time when people are looking at this more than ever, having big negative hits is the last thing we want because it turns away new investors from taking a long position here. Despite the
AZRH
for real for real 5 minutes ago
Are you off your meds self proclaimed king. You and your other alias both trying to bring it down today. Definitely see which side you are really on.
ELTP
Mike198571 Mike198571 5 minutes ago
Based on last 10K

Based on the financials and structure of GlobeStar Therapeutics Corp, here’s an estimated pricing analysis of its OTC shell value:

Key Financials & Red Flags

1. Negative Shareholder Equity: $(1.62M)


2. Debt & Liabi
GSTC

Your Recent History

Delayed Upgrade Clock